Nasdaq: ODTX
Odyssey Therapeutics insiders
The officers, directors and 10% owners of Odyssey Therapeutics, Inc. who hold the most stock, valued at the live ODTX price.
$18.34
ODTX today −$640K (−3.37%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 4
- Their ODTX stock
- $78.2M
- Market value
- $882M
- Held by ranked insiders
- 8.87%
Insiders by value of ODTX holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Dimension Capital II, L.P. | Director | 3,333,516 | $61.1M | 6.94% | Corporate |
| 2 | Gary D. Glick | See Remarks | 415,973 | $7.6M | 0.87% | 10716th |
| 3 | Jeffrey M. Leiden | Director | 270,198 | $5.0M | 0.56% | 4636th |
| 4 | Ian F. Smith | Director | 246,100 | $4.5M | 0.51% | 13673rd |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Odyssey Therapeutics; see each profile for the filing.